Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. NOVA LABORATORIES LIMITED
FDA Inspection
•NOVA LABORATORIES LIMITED•September 18, 2026

NOVA LABORATORIES LIMITED – FDA Inspection, Sep 18, 2026

Record Details

This FDA Inspection record concerns NOVA LABORATORIES LIMITED, with an inspection on September 18, 2026, issued by the Office of Inspections and Investigations, covering human drugs.

Company
NOVA LABORATORIES LIMITED
Inspection Date
September 18, 2026
Product Type
Human Drugs
Office
Office of Inspections and Investigations
People
  • Patty P. Kaewussdangkul (FDA Associated Person)
  • Victoria Spivak (FDA Associated Person)
View Company Profile

ID · 76a5a983-d14a-47b9-8950-7c350d4c700b

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1336522
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued

FDA Citations

8
  1. 21 CFR 211.100(a)Absence of Written Procedures
  2. 21 CFR 211.160(a)Following/documenting laboratory controls
  3. 21 CFR 211.160(b)Scientifically sound laboratory controls
  4. 21 CFR 211.165(a)Testing and release for distribution
  5. 21 CFR 211.188(b)(7)Actual yield, % of theoretical yield
  6. 21 CFR 211.188(b)(8)Labeling control records including specimens or copies
  7. 21 CFR 211.192Investigations of discrepancies, failures
  8. 21 CFR 211.67(b)(3)Cleaning SOPs/instructions

Full citation text and observation details available on the Dashboard.

Other FDA inspections of NOVA LABORATORIES LIMITED

8
DateClassificationOfficeProject area
July 10, 2025NAICenter for Devices and Radiological HealthCompliance: Devices
August 23, 2024VAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
March 12, 2019VAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
February 28, 2019VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
May 11, 2018Not classifiedOffice of Inspections and Investigations
View all 8 other inspections on the company page
Other documents for NOVA LABORATORIES LIMITED
  • FDA Inspection 1278227 - 2025-07-10
  • FDA Inspection 1247224 - 2024-08-23
  • FDA Inspection 1082524 - 2019-03-12
  • FDA Inspection 1089880 - 2019-02-28
  • FDA Inspection 1054742 - 2018-05-11

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore NOVA LABORATORIES LIMITED
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.